摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[2,2′]bithiophenyl-5-ylpyrimidine | 1332462-26-6

中文名称
——
中文别名
——
英文名称
5-[2,2′]bithiophenyl-5-ylpyrimidine
英文别名
5-[2,2']bithiophenyl-5-yl-pyrimidine;5-[2,2'-Bithiophen]-5-ylpyrimidine;5-(5-thiophen-2-ylthiophen-2-yl)pyrimidine
5-[2,2′]bithiophenyl-5-ylpyrimidine化学式
CAS
1332462-26-6
化学式
C12H8N2S2
mdl
——
分子量
244.341
InChiKey
ZQYHJVIMAOMRKH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    82.3
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    作为一个新的抗分枝杆菌化合物家族,C(4)和/或C(5)噻吩基取代的嘧啶的合成及其与结构-活性的关系
    摘要:
    铃木交叉偶联和亲核氢取代的结合(小号ñH)反应被证明是从市售的5-溴嘧啶合成C(4)和/或C(5)单(噻吩基)和二(噻吩基)取代的嘧啶的简便方法。所有新的嘧啶被发现是在微摩尔浓度的活性在体外针对ħ 37 RV,鸟,terrae,利福平的和异烟肼耐药的菌株结核分枝杆菌。对于这些化合物,已经获得了小鼠急性体内毒性的数据,这些化合物似乎是有希望的抗结核药。
    DOI:
    10.1016/j.ejmech.2015.05.007
点击查看最新优质反应信息

文献信息

  • Palladium‐Catalysed Direct Monoarylation of Bithiophenyl Derivatives or Bis(thiophen‐2‐yl)methanone with Aryl Bromides
    作者:Karima Si Larbi、Safia Djebbar、Henri Doucet
    DOI:10.1002/ejic.201100294
    日期:2011.8
    Arylated bithiophenes, which are useful compounds due to their coordination and/or physical properties, can be easily prepared by palladium-catalysed C–H bond activation of heteroaromatics followed by arylation using electron-deficient aryl bromides. A variety of 5-arylated 2,2′-bithiophenyl derivatives have been prepared. Good yields were generally obtained by using the air-stable [PdCl(dppb)(C3H5)]
    芳基化联噻吩由于其配位和/或物理性质而成为有用的化合物,可以通过钯催化的杂芳烃的 C-H 键活化,然后使用缺电子的芳基溴化物进行芳基化来轻松制备。已经制备了多种 5-芳基化 2,2'-联噻吩衍生物。通过使用空气稳定的 [PdCl(dppb)(C3H5)] 配合物作为催化剂,通常可以获得良好的产率。芳基溴上的一系列官能团,例如乙酰基、甲酰基、酯、腈、三氟甲基、氟和羟烷基,是可以容忍的。
  • Microwave-assisted palladium-catalyzed C–C coupling versus nucleophilic aromatic substitution of hydrogen (SNH) in 5-bromopyrimidine by action of bithiophene and its analogues
    作者:Egor V. Verbitskiy、Ekaterina M. Cheprakova、Ekaterina F. Zhilina、Mikhail I. Kodess、Marina A. Ezhikova、Marina G. Pervova、Pavel A. Slepukhin、Julia O. Subbotina、Aleksandr V. Schepochkin、Gennady L. Rusinov、Oleg N. Chupakhin、Valery N. Charushin
    DOI:10.1016/j.tet.2013.04.062
    日期:2013.6
    5-Bromopyrimidine reacts with 2,2'-bithiophene, [2,2':5',2 '']terthiophene and 2-phenylthiophene in the presence of a palladium catalyst to give 5-(het)aryl substituted pyrimidines due to the palladium-catalyzed aryl-aryl C-C coupling. However 5-bromo-4-(het)aryl-pyrimidines have been prepared from the same starting materials through the S-N(H)-reaction catalyzed by a Lewis acid. Conditions for both types of reactions were optimized. All components of the reaction mixtures, including by-products, have been elucidated by gas-liquid chromatography/mass-spectrometry. Evidence for the structure of 4- and 5-bithiophenyl-substituted pyrimidines has first been obtained by means of X-ray crystallography analysis. Molecular orbital calculations (TDDFT), as well as the redox and optical measurements for all new compounds have also been performed. (C) 2013 Elsevier Ltd. All rights reserved.
  • Synthesis, and structure–activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds
    作者:Egor V. Verbitskiy、Ekaterina M. Cheprakova、Pavel A. Slepukhin、Marionella A. Kravchenko、Sergey N. Skornyakov、Gennady L. Rusinov、Oleg N. Chupakhin、Valery N. Charushin
    DOI:10.1016/j.ejmech.2015.05.007
    日期:2015.6
    Combination of the Suzuki cross-coupling and nucleophilic aromatic substitution of hydrogen (SNH) reactions proved to be a convenient method for the synthesis of C(4) and/or C(5) mono(thienyl) and di(thienyl) substituted pyrimidines from commercially available 5-bromopyrimidine. All new pyrimidines were found to be active in micromolar concentrations in vitro against H37Rv, avium, terrae, rifampicin
    铃木交叉偶联和亲核氢取代的结合(小号ñH)反应被证明是从市售的5-溴嘧啶合成C(4)和/或C(5)单(噻吩基)和二(噻吩基)取代的嘧啶的简便方法。所有新的嘧啶被发现是在微摩尔浓度的活性在体外针对ħ 37 RV,鸟,terrae,利福平的和异烟肼耐药的菌株结核分枝杆菌。对于这些化合物,已经获得了小鼠急性体内毒性的数据,这些化合物似乎是有希望的抗结核药。
查看更多

同类化合物

试剂2,2'-Thieno[3,2-b]thiophene-2,5-diylbis-3-thiophenecarboxylicacid 苯并[b]噻吩,3-(2-噻嗯基)- 甲基[2,3'-联噻吩]-5-羧酸甲酯 牛蒡子醇 B 十四氟-Alpha-六噻吩 三丁基(5''-己基-[2,2':5',2''-三联噻吩]-5-基)锡 α-四联噻吩 α-六噻吩 α-五联噻吩 α-七噻吩 α,ω-二己基四噻吩 5,5′-双(3-己基-2-噻吩基)-2,2′-联噻吩 α,ω-二己基六联噻吩 Α-八噻吩 alpha-三联噻吩甲醇 alpha-三联噻吩 [3,3-Bi噻吩]-2,2-二羧醛 [2,2’]-双噻吩-5,5‘-二甲醛 [2,2':5',2''-三联噻吩]-5,5''-二基双[三甲基硅烷] [2,2'-联噻吩]-5-甲醇,5'-(1-丙炔-1-基)- [2,2'-联噻吩]-5-甲酸甲酯 [2,2'-联噻吩]-5-乙酸,a-羟基-5'-(1-炔丙基)-(9CI) C-[2,2-二硫代苯-5-基甲基]胺 5’-己基-2,2’-联噻吩-5-硼酸频哪醇酯 5-辛基-1,3-二(噻吩-2-基)-4H-噻吩并[3,4-c]吡咯-4,6(5H)-二酮 5-苯基-2,2'-联噻吩 5-溴5'-辛基-2,2'-联噻吩 5-溴-5′-己基-2,2′-联噻吩 5-溴-5'-甲酰基-2,2':5'2'-三噻吩 5-溴-3,3'-二己基-2,2'-联噻吩 5-溴-3'-癸基-2,2':5',2''-三联噻吩 5-溴-2,2-双噻吩 5-溴-2,2'-联噻吩-5'-甲醛 5-氯-5'-苯基-2,2'-联噻吩 5-氯-2,2'-联噻吩 5-正辛基-2,2'-并噻吩 5-己基-5'-乙烯基-2,2'-联噻吩 5-己基-2,2-二噻吩 5-全氟己基-5'-溴-2,2'-二噻吩 5-全氟己基-2,2′-联噻吩 5-乙酰基-2,2-噻吩基 5-乙氧基-2,2'-联噻吩 5-丙酰基-2,2-二噻吩 5-{[[2,2'-联噻吩]-5-基}噻吩-2-腈 5-[5-(5-己基噻吩-2-基)噻吩-2-基]噻吩-2-羧酸 5-(羟甲基)-[2,2]-联噻吩 5-(噻吩-2-基)噻吩-2-甲腈 5-(5-甲酰基-3-己基噻吩-2-基)-4-己基噻吩-2-甲醛 5-(5-甲基噻吩-2-基)噻吩-2-甲醛 5-(5-噻吩-2-基噻吩-2-基)噻吩-2-羧酸 5-(5-乙炔基噻吩-2-基)噻吩-2-甲醛